{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:16:09Z","timestamp":1790093769108,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.xagr.2021.100041","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:45:20Z","timestamp":1638567920000},"page":"100041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thromboembolic safety of norethisterone vs levonorgestrel in combined oral contraceptive users: a pooled analysis of 4 large prospective cohort studies"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9236-1396","authenticated-orcid":false,"given":"Clare","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Bauerfeind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Von Stockum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2021.100041_bib0001","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.xagr.2021.100041_bib0002","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2021.100041_bib0003","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/whe.15.82","article-title":"Oral steroid contraception","volume":"11","author":"Sech","year":"2015","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.xagr.2021.100041_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xagr.2021.100041_bib0005","first-page":"59","article-title":"Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta-analysis","volume":"45","author":"Bateson","year":"2016","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.xagr.2021.100041_bib0006","first-page":"e757","article-title":"Half a century of the oral contraceptive pill: historical review and view to the future","volume":"58","author":"Liao","year":"2012","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.xagr.2021.100041_bib0007","article-title":"Types of progestogens in combined oral contraception: effectiveness and side-effects","volume":"11","author":"Lawrie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl2","key":"10.1016\/j.xagr.2021.100041_bib0008","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.3109\/13625187.2010.513071","article-title":"History of oral contraception","volume":"15","author":"Dhont","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.xagr.2021.100041_bib0009","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2021.100041_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.18773\/austprescr.2015.002","article-title":"Choosing a combined oral contraceptive pill","volume":"38","author":"Stewart","year":"2015","journal-title":"Aust Prescr"},{"key":"10.1016\/j.xagr.2021.100041_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2021.100041_bib0012","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.xagr.2021.100041_bib0013","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.xagr.2021.100041_bib0014","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2016.01.012","article-title":"Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives","volume":"93","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.xagr.2021.100041_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2288-9-77","article-title":"International active surveillance study of women taking oral contraceptives (INAS-OC study)","volume":"9","author":"Dinger","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.xagr.2021.100041_bib0016","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ije\/17.4.955","article-title":"A strengthening programme for weak associations","volume":"17","author":"Rothman","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.xagr.2021.100041_bib0017","unstructured":"Guo S, Frase MW. Propensity Score Analysis. Statistical Methods and Applications. Vol. 11. Series: Advanced Quantitative Techniques in the Social Sciences. 2nd ed. Thousand Oaks, CA: SAGE Publications, Inc; 2014"},{"key":"10.1016\/j.xagr.2021.100041_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.xagr.2021.100041_bib0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1257\/jel.47.1.5","article-title":"Recent developments in the econometrics of program evaluation","volume":"47","author":"Imbens","year":"2009","journal-title":"J Econ Lit"},{"key":"10.1016\/j.xagr.2021.100041_bib0020","series-title":"The SAS System for Windows, Release 9.4. Cary, NC:","year":"2013"},{"key":"10.1016\/j.xagr.2021.100041_bib0021","article-title":"A household panel as a tool for cost-effective health-related population surveys: validity of the \u201cHealthcare Access Panel","volume":"2","author":"Potthoff","year":"2004","journal-title":"Ger Med Sci"},{"key":"10.1016\/j.xagr.2021.100041_bib0022","unstructured":"European Medicines Agency. Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks\u2014CHMP endorses PRAC recommendation. 2021. Available at:https:\/\/www.ema.europa.eu\/en\/news\/benefits-combined-hormonal-contraceptives-chcs-continue-outweigh-risks-chmp-endorses-prac. Accessed October 29, 2021."},{"key":"10.1016\/j.xagr.2021.100041_bib0023","unstructured":"FSRH Clinical Effectiveness Unit. Statement from the Clinical Effectiveness Unit: combined hormonal contraception and venous thromboembolism. 2016. Available at:https:\/\/www.fsrh.org\/news\/statement-from-the-clinical-effectiveness-unit-combined\/. Accessed August 23, 2018."},{"key":"10.1016\/j.xagr.2021.100041_bib0024","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/AOG.0b013e3182a5ec6b","article-title":"Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring","volume":"122","author":"Dinger","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2021.100041_bib0025","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2021.100041_bib0026","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2021.100041_bib0027","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2021.100041_bib0028","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2021.100041_bib0029","article-title":"Guidelines on clinical investigation of steoird contraceptives in women","author":"European Medicines","year":"2005","journal-title":"Doc. Ref."},{"key":"10.1016\/j.xagr.2021.100041_bib0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/aje\/kwm165","article-title":"The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study","volume":"166","author":"Fewell","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.xagr.2021.100041_bib0031","article-title":"Residual confounding lurking in big data: a source of error","author":"Danziger","year":"2016","journal-title":"Cham (Chem)"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577821000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577821000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:19:07Z","timestamp":1763000347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577821000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2666577821000393"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2021.100041","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboembolic safety of norethisterone vs levonorgestrel in combined oral contraceptive users: a pooled analysis of 4 large prospective cohort studies","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2021.100041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100041"}}